Healthcare

Cryoport (CYRX) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect

Cryoport (CYRX) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect

Ticker: CYRX | Exchange: NASDAQ | Report Date: March 3, 2026, after market close Cryoport, the specialized cold chain logistics…

Rigel Pharmaceuticals (RIGL) Set to Report Q4 FY2025 Earnings After the Bell — Here’s What to Expect

Ticker: RIGL | Exchange: NASDAQ | Report Date: March 3, 2026, after market close Rigel Pharmaceuticals, a specialty pharma company…

Earnings Summary: Zymeworks (ZYME) Q4 FY25 net loss widens

Zymeworks Inc. (NASDAQ: ZYME), a Canada-based clinical-stage biotechnology company, on Monday reported a wider net loss for the fourth quarter…

Earnings Summary: A snapshot of Smith+Nephew’s (SNN) Q4 2025 report

Smith+Nephew (NYSE: SNN) reported revenue growth across its operating segments for the fourth quarter of fiscal 2025. The medical technology…

Sleep Tech Demand Fuels ResMed

Executive Summary ResMed has transitioned from a cyclical medical device manufacturer into a structurally growing digital health platform anchored in…

BrightSpring Health Services Q4 FY25 earnings jump on strong revenue growth

BrightSpring Health Services, Inc. (NASDAQ: BTSG), a provider of home and community-based health services, on Friday reported a sharp increase…

Agilent Q1 Revenue Rises 7%, Net Income Declines

Agilent Technologies Reports Mixed 1Q 2026 Financial Results An analysis of recent data released via infographic on Agilent Technologies, Inc.…

UnitedHealth Group Incorporated (UNH) Drops 5.8% — Developing Story

UnitedHealth Group Incorporated (UNH) Drops 5.8% — Developing Story

Important takeaways from Medtronic’s (MDT) Q3 2026 earnings report

Shares of Medtronic Plc (NYSE: MDT) declined this week, despite the company reporting stronger-than-expected Q3 2026 earnings. Investors were unsettled…

Pulse Biosciences Shares Fall After Q4 Loss Widens as Clinical Spending Rises and Revenue Remains Limited

Shares of Pulse Biosciences Inc. (Nasdaq: PLSE) were down about 2% in afternoon trading on Thursday after the company reported…